A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Abb Vie Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 557,332 shares of ABBV stock, worth $98.6 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
557,332
Previous 300,926 85.21%
Holding current value
$98.6 Million
Previous $51.6 Million 113.24%
% of portfolio
0.22%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $42 Million - $51.1 Million
256,406 Added 85.21%
557,332 $110 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $11.5 Million - $13.4 Million
-73,987 Reduced 19.73%
300,926 $51.6 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $51.1 Million - $58.3 Million
319,887 Added 581.34%
374,913 $68.3 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $2.34 Million - $2.64 Million
17,005 Added 44.73%
55,026 $8.53 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $2.58 Million - $2.98 Million
-19,300 Reduced 33.67%
38,021 $5.67 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $946,386 - $1.18 Million
7,142 Added 14.23%
57,321 $7.72 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $9.02 Million - $10.4 Million
-62,408 Reduced 55.43%
50,179 $8 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $159 Million - $190 Million
-1,146,669 Reduced 91.06%
112,587 $18.2 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $19.2 Million - $22 Million
-142,689 Reduced 10.18%
1,259,256 $169 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $6.75 Million - $8.58 Million
49,021 Added 3.62%
1,401,945 $215 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $106 Million - $132 Million
804,700 Added 146.78%
1,352,924 $219 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $13 Million - $16.4 Million
-121,000 Reduced 18.08%
548,224 $74.2 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $14.2 Million - $16.1 Million
-133,700 Reduced 16.65%
669,224 $72.2 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $37 Million - $41.3 Million
352,039 Added 78.08%
802,924 $90.4 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $11.2 Million - $12.3 Million
109,300 Added 32.0%
450,885 $48.8 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $4.41 Million - $5.95 Million
-54,793 Reduced 13.82%
341,585 $36.6 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $16.3 Million - $19.2 Million
190,200 Added 92.25%
396,378 $34.7 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $6.43 Million - $8.6 Million
-87,614 Reduced 29.82%
206,178 $20.2 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $6.17 Million - $9.35 Million
95,600 Added 48.24%
293,792 $22.4 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $15.1 Million - $18.9 Million
-209,537 Reduced 51.39%
198,192 $17.5 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $9.51 Million - $11.4 Million
151,079 Added 58.87%
407,729 $30.9 Million
Q2 2019

Aug 09, 2019

SELL
$65.7 - $83.98 $18.8 Million - $24 Million
-285,900 Reduced 52.7%
256,650 $18.7 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $20.2 Million - $23.7 Million
261,300 Added 92.91%
542,550 $43.7 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $895,274 - $1.1 Million
-11,500 Reduced 3.93%
281,250 $25.9 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $1.14 Million - $1.27 Million
-12,800 Reduced 4.19%
292,750 $27.7 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $44.3 Million - $52.4 Million
-493,000 Reduced 61.74%
305,550 $28.3 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $33.9 Million - $45.4 Million
368,800 Added 85.82%
798,550 $75.6 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $8.33 Million - $9.13 Million
-93,000 Reduced 17.79%
429,750 $41.6 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $36.5 Million - $46.6 Million
522,750
522,750 $46.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.